Ruiyun Cold Chain has raised 100 million yuan ($15 million) in a pre-A round, while AI drug discovery platform Galixir has completed a new round of financing from Yunfeng Capital, DCM, and others.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
